ArticleClinical and translational allergy2012
Control of Allergic Rhinitis and Asthma Test (CARAT) can be used to assess individual patients over time.
Article in Clinical and translational allergy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice.Frontiers in allergy · 2024Article
- Article
- Control of Allergic Rhinitis and Asthma Test: A systematic review of measurement properties and COSMIN analysis.Clinical and translational allergy · 2022Review
- Prevalence and Characterisation of Patients with Asthma According to Disease Severity in Portugal: Findings from the EPI-ASTHMA Pilot Study.Journal of asthma and allergy · 2022Article
- Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®.Clinical and translational allergy · 2021Review
- Feasibility and Acceptability of an Asthma App to Monitor Medication Adherence: Mixed Methods Study.JMIR mHealth and uHealth · 2021Observational
- Allergic rhinitis characterization in community pharmacy customers: a cross-sectional study.International journal of clinical pharmacy · 2021Article
- The Measurement of Asthma and Allergic Rhinitis Control in Children and Adolescents.Children (Basel, Switzerland) · 2020Article
- Patient-physician discordance in assessment of adherence to inhaled controller medication: a cross-sectional analysis of two cohorts.BMJ open · 2019Observational
- Prospective observational study validating the German version of the Control of Allergic Rhinitis and Asthma Test (CARAT10).NPJ primary care respiratory medicine · 2018Observational
- Control of Allergic Rhinitis and Asthma Test with 1-week recall: Validation of paper and electronic version.Allergy · 2018Article
- The Portuguese Severe Asthma Registry: Development, Features, and Data Sharing Policies.BioMed research international · 2018Article
- Self-management research of asthma and good drug use (SMARAGD study): a pilot trial.International journal of clinical pharmacy · 2017Article
- Allergic respiratory disease (ARD), setting forth the basics: proposals of an expert consensus report.Clinical and translational allergy · 2017Article
- The minimal clinically important difference of the Control of Allergic Rhinitis and Asthma Test (CARAT): cross-cultural validation and relation with pollen counts.NPJ primary care respiratory medicine · 2015Article
- A common language to assess allergic rhinitis control: results from a survey conducted during EAACI 2013 Congress.Clinical and translational allergy · 2015Article
- Development process and cognitive testing of CARATkids - Control of Allergic Rhinitis and Asthma Test for children.BMC pediatrics · 2014Observational
- Control of Allergic Rhinitis and Asthma Test (CARAT): dissemination and applications in primary care.Primary care respiratory journal : journal of the General Practice Airways Group · 2013Article
- Assessment of disease control in allergic rhinitis.Clinical and translational allergy · 2013Article
- Mite-Allergic Rhinitis: How to Evaluate Clinical Efficacy in Allergen-Specific Immunotherapy Trials?Current treatment options in allergyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
unlabelled
backgroundThe Control of Allergic Rhinitis and Asthma Test (CARAT10) has been proposed as the first tool to implement the Allergic Rhinitis and its Impact on Asthma initiative guidelines in clinical practice. To serve this purpose, it must have adequate properties to assess the control of an individual over time. This study aimed to prospectively assess the test-retest reliability, responsiveness and longitudinal validity of CARAT10.
methodsAdults with asthma and allergic rhinitis were enrolled at 4 outpatient clinics of Portuguese central hospitals. At each of the two visits, 4 to 6 weeks apart, patients filled out CARAT10 and additional questionnaires, followed by a medical evaluation blinded to the questionnaires' answers.
resultsFrom the 62 patients included, 51 patients completely filled out CARAT10 at both visits. The test-retest reliability, computed as an intra-class correlation coefficient, was 0.82. Regarding responsiveness, a significant change (p = 0.002) of CARAT10 score in clinically unstable patients was observed (95%CI -5.08; -1.31) and the Guyatt's responsiveness index was 1.54. As for the longitudinal validity assessment, the correlation coefficients of the changes of CARAT10 scores with those of ACQ5 and symptoms VAS ranged from 0.49 to 0.65, while with the physician assessment of control they ranged from 0.31 to 0.41.
conclusionCARAT10 has good test-retest reliability, responsiveness and longitudinal validity. It can be used to assess control of allergic rhinitis and asthma, both to compare groups in clinical studies and to evaluate individual patients in clinical practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.